Concepedia

Camilo Quevedo

CQ

Statistics

Publications

8

Citations

551

H-Index

8

Active since

2008

Affiliations

University of Oxford(Current)

Research Complex at Harwell

Rutherford Appleton Laboratory

MRC Weatherall Institute of Molecular Medicine

John Radcliffe Hospital

Camilo Quevedo is an author at University of Oxford specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

2008–2019

8

Publications

8

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds

Abimael Cruz-Migoni, Peter Canning, Camilo Quevedo et al. · Proceedings of the National Academy of Sciences · 2019 · 139 citations · Full text

, , +17

Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment

Camilo Quevedo, Abimael Cruz-Migoni, Nicolas Béry et al. · Nature Communications · 2018 · 131 citations · Full text

, , +17

A Useful Approach to Identify Novel Small-Molecule Inhibitors of Wnt-Dependent Transcription

Kenneth Ewan, Bożena Pająk, Mark Stubbs et al. · Cancer Research · 2010 · 103 citations · Full text

, , +16

BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions

Nicolas Béry, Abimael Cruz-Migoni, Carole J. R. Bataille et al. · eLife · 2018 · 60 citations · Full text

, , +16

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family

Carole J. R. Bataille, Méabh B. Brennan, Simon Byrne et al. · Bioorganic & Medicinal Chemistry · 2017 · 46 citations · Full text

, , +12

1–5 of 8